An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases
Authors
Keywords
-
Journal
MOLECULES
Volume 26, Issue 15, Pages 4629
Publisher
MDPI AG
Online
2021-08-02
DOI
10.3390/molecules26154629
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Machine learning, artificial intelligence, and data science breaking into drug design and neglected diseases
- (2021) José Peña‐Guerrero et al. Wiley Interdisciplinary Reviews-Computational Molecular Science
- An Overview on the Therapeutics of Neglected Infectious Diseases—Leishmaniasis and Chagas Diseases
- (2021) Brindha J et al. Frontiers in Chemistry
- QSAR Modeling for Multi-Target Drug Discovery: Designing Simultaneous Inhibitors of Proteins in Diverse Pathogenic Parasites
- (2021) Valeria V. Kleandrova et al. Frontiers in Chemistry
- Trends in the Epidemiology of Leishmaniasis in the City of Barcelona (1996–2019)
- (2021) David Palma et al. Frontiers in Veterinary Science
- Unveiling the targets involved in quest of antileishmanial leads using in-silico methods.
- (2020) Pone Kamdem Boniface et al. CURRENT DRUG TARGETS
- Searching drugs for Chagas disease, leishmaniasis and schistosomiasis: a brief review
- (2020) Soraya Silva Santos et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Neglected tropical diseases: an effective global response to local poverty-related disease priorities
- (2020) Dirk Engels et al. Infectious Diseases of Poverty
- Computationally designed synthetic peptides for transporter proteins imparts allostericity in Miltefosine resistant L. major
- (2020) Ritika Kabra et al. BIOCHEMICAL JOURNAL
- An Insight into the Current Perspective and Potential Drug Targets for Visceral Leishmania (VL)
- (2020) Rani Mansuri et al. CURRENT DRUG TARGETS
- The current drug discovery landscape for trypanosomiasis and leishmaniasis: Challenges and strategies to identify drug targets
- (2020) Fernando Altamura et al. DRUG DEVELOPMENT RESEARCH
- Identification of Inhibitors to Trypanosoma cruzi Sirtuins Based on Compounds Developed to Human Enzymes
- (2020) Tanira Matutino Bastos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting Trypanothione Reductase, a Key Enzyme in the Redox Trypanosomatid Metabolism, to Develop New Drugs against Leishmaniasis and Trypanosomiases
- (2020) Theo Battista et al. MOLECULES
- Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling
- (2020) Alfredo Juárez-Saldivar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases
- (2020) Advait Nagle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chalcone‐Quinoline Conjugates as Potential T. cruzi Cruzipain Inhibitors: Docking Studies, Molecular Dynamics and Evaluation of Drug‐Likeness
- (2020) Andrés F. Yepes et al. ChemistrySelect
- Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation
- (2020) Jaspreet Toor et al. CLINICAL INFECTIOUS DISEASES
- Cell death pathways in pathogenic trypanosomatids: lessons of (over)kill
- (2019) Rubem Figueiredo Sadok Menna-Barreto Cell Death & Disease
- In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei
- (2019) Julio Alberto Rojas Vargas et al. PARASITOLOGY RESEARCH
- The molecular machinery of regulated cell death
- (2019) Daolin Tang et al. CELL RESEARCH
- Overview of Recent Strategic Advances in Medicinal Chemistry
- (2019) Gaochan Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chemical Constituents of Anacardium occidentale as Inhibitors of Trypanosoma cruzi Sirtuins
- (2019) Tanira Matutino Bastos et al. MOLECULES
- Exploiting machine learning for end-to-end drug discovery and development
- (2019) Sean Ekins et al. NATURE MATERIALS
- The proteasome as a target for protozoan parasites
- (2019) Stanley C. Xie et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Biochemical characterization and chemical validation of Leishmania MAP Kinase-3 as a potential drug target
- (2019) Shweta Raj et al. Scientific Reports
- 100 Years of Suramin
- (2019) Natalie Wiedemar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In silico repositioning of etidronate as a potential inhibitor of the Trypanosoma cruzi enolase
- (2019) Edward A. Valera-Vera et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- 2020: a crucial year for neglected tropical diseases
- (2019) The Lancet LANCET
- Setting Our Sights on Infectious Diseases
- (2019) Manu De Rycker et al. ACS Infectious Diseases
- Current trends in the pharmacological management of Chagas disease
- (2019) Vanessa Ribeiro et al. International Journal for Parasitology-Drugs and Drug Resistance
- Genistein and Ascorbic Acid reduce oxidative stress-derived DNA damage induced by antileishmanial meglumine antimoniate
- (2018) Luís Cláudio Lima de Jesus et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of chalcone-based antileishmanial agents targeting trypanothione reductase
- (2018) Margherita Ortalli et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- PDL-1 Blockade Prevents T Cell Exhaustion, Inhibits Autophagy, and Promotes Clearance of Leishmania donovani
- (2018) Samar Habib et al. INFECTION AND IMMUNITY
- Chagas disease
- (2018) José A Pérez-Molina et al. LANCET
- In Silico Discovery of a Substituted 6-Methoxy-quinalidine with Leishmanicidal Activity in Leishmania infantum
- (2018) Strahinja Stevanović et al. MOLECULES
- How artificial intelligence is changing drug discovery
- (2018) Nic Fleming NATURE
- Innovation in neglected tropical disease drug discovery and development
- (2018) Hong-Bo Weng et al. Infectious Diseases of Poverty
- A Phase III Diagnostic Accuracy Study of a Rapid Diagnostic Test for Diagnosis of Second-Stage Human African Trypanosomiasis in the Democratic Republic of the Congo
- (2018) Marleen Boelaert et al. EBioMedicine
- Challenges and recent progress in drug discovery for tropical diseases
- (2018) Manu De Rycker et al. NATURE
- Human Kinetoplastid Protozoan Infections: Where Are We Going Next?
- (2018) Alessandra Almeida Filardy et al. Frontiers in Immunology
- Efficacy of sertraline against Trypanosoma cruzi: an in vitro and in silico study
- (2018) Daiane Dias Ferreira et al. JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES
- Drug Discovery for Kinetoplastid Diseases: Future Directions
- (2018) Srinivasa P. S. Rao et al. ACS Infectious Diseases
- Butenolides from Nectandra oppositifolia (Lauraceae) displayed anti-Trypanosoma cruzi activity via deregulation of mitochondria
- (2018) Geanne A. Alves Conserva et al. PHYTOMEDICINE
- Synthesis and antitrypanosomal activities of novel pyridylchalcones
- (2017) Avninder S. Bhambra et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and molecular modelling studies of phenyl linked oxadiazole-phenylhydrazone hybrids as potent antileishmanial agents
- (2017) Muhammad Taha et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- In silico identification of inhibitors of ribose 5-phosphate isomerase from Trypanosoma cruzi using ligand and structure based approaches
- (2017) Vanessa de V. C. Sinatti et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need
- (2017) Mark C. Field et al. NATURE REVIEWS MICROBIOLOGY
- Chemotherapy of leishmaniasis: present challenges
- (2017) SILVIA R. B. ULIANA et al. PARASITOLOGY
- Ten failings in global neglected tropical diseases control
- (2017) Peter J. Hotez PLoS Neglected Tropical Diseases
- Design, synthesis, molecular docking and biological evaluation of thiophen-2-iminothiazolidine derivatives for use against Trypanosoma cruzi
- (2016) E.F. Silva-Júnior et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Antileishmanial activity of novel indolyl–coumarin hybrids: Design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction
- (2016) Jaiprakash N. Sangshetti et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and evaluation against Leishmania amazonensis of novel pyrazolo[3,4- d ]pyridazinone- N -acylhydrazone-(bi)thiophene hybrids
- (2016) Andrey P. Jacomini et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
- (2016) Shilpi Khare et al. NATURE
- Oleanolic acid (OA) as an antileishmanial agent: Biological evaluation and in silico mechanistic insights
- (2016) Tahira Souza Melo et al. PARASITOLOGY INTERNATIONAL
- Update: biological and chemical aspects of Nectandra genus (Lauraceae)
- (2016) Simone S. Grecco et al. TETRAHEDRON-ASYMMETRY
- New Approaches to Overcome Transport Related Drug Resistance in Trypanosomatid Parasites
- (2016) Jose A. Garcia-Salcedo et al. Frontiers in Pharmacology
- Cutaneous Leishmaniasis: Recent Developments in Diagnosis and Management
- (2015) Henry J. C. de Vries et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Antileishmanial, DNA Interaction, and Docking Studies of Some Ferrocene-Based Heteroleptic Pentavalent Antimonials
- (2015) Muhammad Khawar Rauf et al. ARCHIV DER PHARMAZIE
- Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents
- (2015) César Mendoza-Martínez et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis
- (2015) Elisangela Oliveira Freitas et al. PLoS Neglected Tropical Diseases
- Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites
- (2015) Jessica A. Engel et al. International Journal for Parasitology-Drugs and Drug Resistance
- Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning
- (2015) Marcel Kaiser et al. PLoS One
- Binding to Large Enzyme Pockets: Small-Molecule Inhibitors of Trypanothione Reductase
- (2014) Elke Persch et al. ChemMedChem
- Treatment options for second-stage gambiense human African trypanosomiasis
- (2014) Gilles Eperon et al. Expert Review of Anti-Infective Therapy
- The main sceneries of Chagas disease transmission. The vectors, blood and oral transmissions - A comprehensive review
- (2014) José Rodrigues Coura MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Anti-Trypanosoma cruzi and anti-leishmanial activity by quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives
- (2014) Juan Carlos Villalobos-Rocha et al. PARASITOLOGY RESEARCH
- Global distribution maps of the leishmaniases
- (2014) David M Pigott et al. eLife
- Chemical–biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-target
- (2013) Jonathan W Choy et al. Beilstein Journal of Organic Chemistry
- Cheminformatic models based on machine learning for pyruvate kinase inhibitors of Leishmania mexicana
- (2013) Salma Jamal et al. BMC BIOINFORMATICS
- Ask the Experts: Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease
- (2013) Future Medicinal Chemistry
- Use of clomipramine as chemotherapy of the chronic phase of Chagas disease
- (2013) ROMINA FAURO et al. PARASITOLOGY
- Bisphosphonate metal complexes as selective inhibitors of Trypanosoma cruzi farnesyl diphosphate synthase
- (2012) Bruno Demoro et al. DALTON TRANSACTIONS
- Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis
- (2012) P. P. SIMARRO et al. PARASITOLOGY
- State of the Art in African Trypanosome Drug Discovery
- (2011) Robert T. Jacobs et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Functional characterization of NADP-dependent isocitrate dehydrogenase isozymes from Trypanosoma cruzi
- (2011) Alejandro E. Leroux et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Drug discovery and development for neglected diseases: the DNDi model
- (2011) Jean-Robert Ioset et al. Drug Design Development and Therapy
- Knockout of the dhfr-ts Gene in Trypanosoma cruzi Generates Attenuated Parasites Able to Confer Protection against a Virulent Challenge
- (2011) Cecilia Perez Brandan et al. PLoS Neglected Tropical Diseases
- Computer-Aided Identification ofTrypanosoma bruceiUridine Diphosphate Galactose 4′-Epimerase Inhibitors: Toward the Development of Novel Therapies for African Sleeping Sickness
- (2010) Jacob D. Durrant et al. JOURNAL OF MEDICINAL CHEMISTRY
- Trypanosoma brucei pteridine reductase 1 is essential for survival in vitro and for virulence in mice
- (2010) Natasha Sienkiewicz et al. MOLECULAR MICROBIOLOGY
- N-myristoyltransferase inhibitors as new leads to treat sleeping sickness
- (2010) Julie A. Frearson et al. NATURE
- Targeting essential pathways in trypanosomatids gives insights into protozoan mechanisms of cell death
- (2010) Despina Smirlis et al. Parasites & Vectors
- The crystal structure of trypanothione reductase from the human pathogen Trypanosoma cruzi at 2.3 Å resolution
- (2010) Yihong Zhang et al. PROTEIN SCIENCE
- Synthesis and Evaluation of 1-(1-(Benzo[b]thiophen-2-yl)cyclohexyl)piperidine (BTCP) Analogues as Inhibitors of Trypanothione Reductase
- (2009) Stephen Patterson et al. ChemMedChem
- One Scaffold, Three Binding Modes: Novel and Selective Pteridine Reductase 1 Inhibitors Derived from Fragment Hits Discovered by Virtual Screening
- (2009) Chidochangu P. Mpamhanga et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Design of Pteridine Reductase Inhibitors Targeting African Sleeping Sickness and the Leishmaniases
- (2009) Lindsay B. Tulloch et al. JOURNAL OF MEDICINAL CHEMISTRY
- Direct Interaction between Amphotericin B and Ergosterol in Lipid Bilayers As Revealed by2H NMR Spectroscopy
- (2009) Nobuaki Matsumori et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Two approaches to discovering and developing new drugs for Chagas disease
- (2009) JH McKerrow et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- The Burden of Human African Trypanosomiasis
- (2009) Eric M. Fèvre et al. PLoS Neglected Tropical Diseases
- Efficacy of the diamidine DB75 and its prodrug DB289, against murine models of human African trypanosomiasis
- (2008) J.K. Thuita et al. ACTA TROPICA
- An improved relaxed complex scheme for receptor flexibility in computer-aided drug design
- (2008) Rommie E. Amaro et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Discovery of drug-like inhibitors of an essential RNA-editing ligase in Trypanosoma brucei
- (2008) R. E. Amaro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function
- (2008) N. Schormann et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now